Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program

OBJECTIVE: The aim of this study was to assess potential drug–drug interactions between highly purified cannabidiol (CBD) and anti‐seizure medications (ASMs). METHODS: Our group previously reported that in a sample of adults and children receiving CBD in an open‐label expanded access program, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaston, Tyler E., Bebin, E. Martina, Cutter, Gary R., Grayson, Leslie, Szaflarski, Jerzy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690661/
https://www.ncbi.nlm.nih.gov/pubmed/37593907
http://dx.doi.org/10.1002/epi4.12815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690661/
https://www.ncbi.nlm.nih.gov/pubmed/37593907
http://dx.doi.org/10.1002/epi4.12815

Ejemplares similares